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Beckwith-Wiedemann Syndrome and IVF: A Case-
Control Study
To the Editor:
A recent series of observations has suggested a link
between in vitro fertilization (IVF) and imprinting dis-
orders, such as Beckwith-Wiedemann syndrome (BWS
[MIM 130650]) and Angelman syndrome (MIM
105830). BWS is a model imprinting disorder and is
characterized by prenatal and/or postnatal overgrowth,
macroglossia, abdominal-wall defects, neonatal hypo-
glycemia, hemihypertrophy, ear abnormalities, and an
increased risk of embryonal tumors (DeBaun et al.
2002). An analysis of BWS registries from three centers
has shown the proportion of individuals with BWS con-
ceived using IVF to be 3/65 (DeBaun et al. 2003), 6/149
(Maher et al. 2003), and 6/149 (Gicquel et al. 2003).
These data suggest that ∼4% of individuals with BWS
are conceived using IVF, a figure greater than the gen-
erally accepted usage of IVF in these centers. Further
interpretation of these results has been limited because
of a reliance by these studies on case records and ques-
tionnaire data to determine the method of conception
in BWS cases, a lack of the use of appropriate controls,
and a statistical significance that was either borderline
(Gicquel et al. 2003; Maher et al. 2003) or not men-
tioned (DeBaun et al. 2003). A recent review of the ep-
idemiology and molecular biology behind these and
other related studies has highlighted the need for case-
control studies in this area (Niemitz and Feinberg 2004).
We report here the results of what we believe is the first
case-control study done to test the null hypothesis that
there is no difference between the rate of IVF in BWS
cases and that in non-BWS controls, in an Australian
population.
The present study was possible because the State of
Victoria, Australia, is serviced by a single clinical genetics
service and laboratory providing molecular tests for
BWS. This allowed complete ascertainment of children
born in Victoria between 1983 and 2003 and diagnosed
with BWS by a clinical geneticist. Only cases meeting
the DeBaun criteria (DeBaun and Tucker 1998) were
included in this study. Appropriate controls were ob-
tained using data from the Victorian Perinatal Data Col-
lection Unit, which registers all births of 119-wk ges-
tation. For each BWS case, four live-born controls were
randomly selected from babies born within 1 mo of that
case, in which parity was 1 and the maternal age was
within 1 year of the risk-set case. Manual record linkage
was then used to determine if the BWS cases and the
controls were recorded in the databases of the providers
of IVF services in Victoria, with the use of maternal
names and the dates of birth of mothers and babies.
Ethics approval was obtained from all sites providing
data. Statistical significance of differences in proportions
between groups was assessed using Epi Info, with results
expressed as odds ratios (ORs) and as Fisher’s-exact-test
two-sided P values to account for cell sizes !5.
Among ∼1,316,500 live births in Victoria between
1983 and 2003 (2003 data were estimated, as they were
known to be very similar to 2002 data), 37 cases of
BWS were detected, giving an overall BWS prevalence
of ∼1/35,580 live births for this period. The average
maternal age for BWS cases was 27.0 years. Record link-
age of the 37 BWS cases and 148 matched controls iden-
tified IVF as the method of conception in 4 BWS cases
(10.81%) and in 1 control (0.67%), giving an OR of
17.8 (95% CI 1.8–432.9), and Fisher’s-exact-test two-
sided . The clinical and molecular features ofPp .006
the four patients with BWS conceived using IVF are
listed in table 1, and the reasons for the use of IVF were
varied (two unexplained infertility, one egg donation,
and one oligospermia). Our results indicate that if a child
has BWS, the odds that the child was conceived using
IVF is ∼18 times greater than that for a child without
BWS, although the magnitude of this OR should be cau-
tiously interpreted, given the wide CI. During the study
period (1983–2003), 14,894 babies were born as a result
of an IVF procedure (excluding gamete intrafallopian
transfer). Using our population-based data, we can then
estimate the absolute risk of having a live-born baby
with BWS when IVF is used as the means of conception
to be 4/14,894.
This study demonstrates that children conceived by
IVF are significantly more likely to have BWS, compared
with children conceived naturally. Our study design with
a control group matched by maternal age has ensured
that the rate of IVF procedures in the control (non-BWS)
population is accurate for the entire study period, which
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Table 1
Clinical Features of Four Patients Diagnosed with BWS Who Were Conceived Using IVF
CLINICAL FEATURE
FINDING IN PATIENT
1 2 3 4
Intracytoplasmic sperm injection No No No Yes
Frozen embryo Yes No Yes Yes
Day of transfer 2 2 2 2
Sex Female Male Male Female
Gestation (wk) 40 33 38 37
Macrosomia Yes Yes Yes No
Hypoglycemia No Yes No Yes
Macroglossia Yes Yes Yes Yes
Ear anomalies Yes No Yes Yes
Abdominal-wall defects Exomphalos No Exomphalos No
Hemihypertrophy No Yes No No
Isolated loss of methylation at KVDMR1/LIT1 Yes Not performed Yes Yes
encompasses a time from infrequent use of IVF (0.2%
of pregnancies in 1983) to more frequent use (3% in
2003). We can quantify, for the first time, the risk of
BWS in our IVF population as ∼1/4,000, or 9 times
greater than in the general population. The mechanisms
underlying this increased risk remain unclear, but this
study and previous studies (DeBaun et al. 2003; Gicquel
et al. 2003; Maher et al. 2003) have shown that patients
with BWS conceived by IVF consistently show isolated
hypomethylation at the maternal KVDMR1/LIT1 locus
at 11p15.5. By comparison, this molecular mechanism
is observed in only 46% of our overall BWS population,
with the remainder of BWS cases resulting from uni-
parental disomy of chromosome 11 (16%), biparental
methylation of H19DMR (7%), or an unidentified mu-
tation (31%). The preponderance of BWS cases con-
ceived by IVF that show hypomethylation of maternal
KVDMR1/LIT1 suggests that collection of in vitro cul-
tures might disturb methylation in the oocyte or early
embryo, predisposing to maternal allele demethylation.
The fact that the overall risk of BWS in children con-
ceived using IVF remains low and that BWS is, in most
cases, associated with a good long-term outcome makes
it unlikely that this finding will deter couples from using
IVF. Nor does it seem necessary to offer prenatal diag-
nosis for BWS to couples undergoing IVF. Questions
remain, however, about potential effects of IVF on other
regions of the genome that are subject to epigenetic reg-
ulation. In this context, the observation of a possible
association between IVF and Angelman syndrome, an-
other disorder resulting from hypomethylation of the
maternal genome, is of some concern (Cox et al. 2002;
Orstavik et al. 2003). Although long-term follow-up
data of children conceived by IVF are generally reas-
suring, it remains possible that alterations in genomic
imprinting might have other unrecognized health im-
plications for children and adults who were conceived
by IVF. Our data reinforce the need for long-term follow-
up studies of children conceived by IVF.
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